Supriya Lifescience Limited (NSE:SUPRIYA)
India
· Delayed Price · Currency is INR 700.50
-4.20 (-0.60%)
Apr 29, 2026, 12:55 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 56.72 billion as of April 28, 2026. Its market cap has decreased by -0.70% in one year.
Market Cap
56.72B
Enterprise Value
55.74B
Revenue
7.35B
Ranking
n/a
PE Ratio
30.59
Stock Price
700.50
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 56.72B, an increase of 80.30%. That is a compound annual growth rate of 14.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 56.72B | -6.23% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zota Health Care | 44.01B |
| Blue Jet Healthcare | 76.96B |
| Concord Biotech | 110.67B |
| Dishman Carbogen Amcis | 28.87B |
| Panacea Biotec | 22.59B |
| OneSource Specialty Pharma | 209.96B |
| Anthem Biosciences | 434.85B |
| TAKE Solutions | 6.57B |